PF-Atlas › Clinical Trials › NCT02858843
The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia
lumacaftor-ivacaftor · Not specified
Registry ID
NCT02858843
Phase
Not specified
Status
Terminated
Drug / intervention
lumacaftor-ivacaftor
Sponsor
Massachusetts General Hospital
Start
2016-08-01
Enrollment
1
About this trial
The purpose of this research study is to find out if the combined therapy lumacaftor-ivacaftor affects glycemia in patient with cystic fibrosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02858843 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.